Investor Presentaiton

LOVEVOLUS JEUVEAU EXTRA- STRENGTH PHASE II DURATION STUDY SUMMARY SAFETY Profile similar across the groups. • . • 88.9% of AE's mild, 11% moderate No serious adverse events DURATION Time to return to baseline among multiple parameters was 26 weeks or 6 months De 31

View entire presentation